ID

33897

Descripción

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01661790

Link

https://clinicaltrials.gov/show/NCT01661790

Palabras clave

Versiones (1)
  1. 6/1/19 6/1/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

6 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Malignant Pleural Effusion NCT01661790

Inglés

Eligibility Malignant Pleural Effusion NCT01661790

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with advanced recurrent or progressive nsclc proven cytohistologically
Descripción

Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent | Non-Small Cell Lung Carcinoma Progressive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278517
UMLS CUI [3,1]
C0007131
UMLS CUI [3,2]
C0205329
karnofsky performance status (kps) ≥60
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
life expectancy ≥ 2 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
no history of severe diseases of major organs including liver, heart, and kidney
Descripción

Absence Disease Organ Major | Absence Liver diseases Severe | Absence Heart Diseases Severe | Absence Kidney Diseases Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0205164
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0023895
UMLS CUI [2,3]
C0205082
UMLS CUI [3,1]
C0332197
UMLS CUI [3,2]
C0018799
UMLS CUI [3,3]
C0205082
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0022658
UMLS CUI [4,3]
C0205082
no previous intrapleural therapy
Descripción

Absence Therapy Intrapleural

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C3282906
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
active thoracic cavity or systemic bleeding
Descripción

Thoracic cavity Hemorrhage | Hemorrhage Systemic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0230139
UMLS CUI [1,2]
C0019080
UMLS CUI [2,1]
C0019080
UMLS CUI [2,2]
C0205373
active pleural or systemic infection.
Descripción

Pleural infection | Sepsis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919907
UMLS CUI [2]
C0243026
known sensitivity to bevacizumab or cisplatin
Descripción

Hypersensitivity Bevacizumab | Cisplatin allergy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0796392
UMLS CUI [2]
C0570702
refusal to participate in the study.
Descripción

Refusal to Participate Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1136454
UMLS CUI [1,2]
C0008976
Volver a la parte superior de la página

Similar models

Eligibility Malignant Pleural Effusion NCT01661790

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent | Non-Small Cell Lung Carcinoma Progressive
Item
patients with advanced recurrent or progressive nsclc proven cytohistologically
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278517 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
Karnofsky Performance Status
Item
karnofsky performance status (kps) ≥60
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 2 months
boolean
C0023671 (UMLS CUI [1])
Absence Disease Organ Major | Absence Liver diseases Severe | Absence Heart Diseases Severe | Absence Kidney Diseases Severe
Item
no history of severe diseases of major organs including liver, heart, and kidney
boolean
C0332197 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0023895 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0018799 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0022658 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
Absence Therapy Intrapleural
Item
no previous intrapleural therapy
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3282906 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Thoracic cavity Hemorrhage | Hemorrhage Systemic
Item
active thoracic cavity or systemic bleeding
boolean
C0230139 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
C0019080 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Pleural infection | Sepsis
Item
active pleural or systemic infection.
boolean
C0919907 (UMLS CUI [1])
C0243026 (UMLS CUI [2])
Hypersensitivity Bevacizumab | Cisplatin allergy
Item
known sensitivity to bevacizumab or cisplatin
boolean
C0020517 (UMLS CUI [1,1])
C0796392 (UMLS CUI [1,2])
C0570702 (UMLS CUI [2])
Refusal to Participate Clinical Trial
Item
refusal to participate in the study.
boolean
C1136454 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial